Corporate News     26-Sep-23
Suven Pharmaceuticals update on acquisition of up to 76% stake by Berhyanda, Cyprus
Suven Pharmaceuticals announced that the company has received an intimation on 25 September 2023, that the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has granted its approval for acquisition of up to 76.1% shareholding in the Company by M/s. Berhyanda, Cyprus (Acquirer) by way of transfer of 12,75,37,043 equity shares aggregating to 50.1% of shareholding in the Company from promoters of the Company (Jasti Property and Equity Holdings) and acquisition of up to 6,61,86,889 equity shares aggregating to 26% of shareholding in the Company from public shareholders through mandatory open offer.

The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the Company.

The Acquirer will hold 76.1% of the paid-up share capital of the Company and other foreign investors including FPIs will hold up to 14% of paid-up share capital of the Company subject to compliance with the regulations under various laws and the terms and conditions as specified in the letter of approval.

Previous News
  Suven Pharmaceuticals to conduct AGM
 ( Corporate News - 15-Jul-24   17:27 )
  Suven Pharmaceuticals receives revision in credit ratings
 ( Corporate News - 12-Mar-24   14:03 )
  Suven Pharmaceuticals fixes record date for final dividend
 ( Market Beat - Reports 08-Jun-21   16:05 )
  Suven Pharmaceuticals consolidated net profit rises 12.05% in the March 2021 quarter
 ( Results - Announcements 08-Jun-21   14:02 )
  Suven Pharmaceuticals to discuss results
 ( Corporate News - 02-Aug-22   20:03 )
  Suven Pharmaceuticals update on acquisition of up to 76% stake by Berhyanda, Cyprus
 ( Corporate News - 26-Sep-23   12:12 )
  Suven Pharmaceuticals standalone net profit rises 8.98% in the June 2023 quarter
 ( Results - Announcements 08-Aug-23   17:05 )
  Suven Pharmaceuticals intimates of fire incident at its Jeedimetla facility
 ( Corporate News - 27-Apr-20   12:13 )
  Suven Pharmaceuticals consolidated net profit rises 12.14% in the June 2023 quarter
 ( Results - Announcements 09-Aug-23   07:43 )
  Suven Pharma Hyderabad facilities clear USFDA inspection
 ( Hot Pursuit - 26-Feb-24   12:13 )
  Volumes soar at Suven Pharmaceuticals Ltd counter
 ( Hot Pursuit - 03-Jan-23   11:00 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top